Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
Saved in:
| Title: | Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia. |
|---|---|
| Authors: | Simon F; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Ligtvoet R; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Fürstenau M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Langerbeins P; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Fink AM; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., von Tresckow J; Department of Hematology, Oncology and Palliative Care, Katholisches Klinikum Bochum, Ruhr University Bochum, Bochum, Germany., Cramer P; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Kutsch N; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Goede V; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Poulsen CB; Department of hematology, Zealand University Hospital, Roskilde, Denmark., Illmer T; Hematology Private Practice, Dresden, Germany., Müller L; Study Centrum Unter Ems, Practice for Oncology and Hematology, Leer, Germany., Vehling-Kaiser U; Outpatient Clinic, Landshut, Germany., Eckart M; Onkologische Schwerpunktpraxis Erlangen, Erlangen, Germany., Staber P; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria., Tadmor T; Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Juliusson G; Department of Hematology, Skåne University Hospital, Lund, Sweden., Thornton P; Department of Haematology, Beaumont Hospital, Dublin, Ireland., Sivcheva L; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria., Loscertales J; Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain., Jentsch-Ullrich K; Gemeinschaftspraxis für Hämatologie und Onkologie, Magdeburg, Germany., Hebart H; Department of Internal Medicine, Hematology and Oncology, Mutlangen, Germany., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Tausch E; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Schneider C; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Stilgenbauer S; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Kater AP; Department of Hematology and Cancer Center Amsterdam, Amsterdam, Netherlands., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Fischer K; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Robrecht S; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Hallek M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Eichhorst B; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Al-Sawaf O; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Jun; Vol. 67 (7), pp. 1620-1626. Date of Electronic Publication: 2026 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2026.2634939 |
